• Sneha Shankar
• Dr. D. Anand

This paper made an effort to analyze the financial performance pre- and post-merger of selected companies of Indian pharma sector. The study covered a period of 10 years from 2010 to 2019. The financial performance was analyzed based on the selected variables covering from profitability, liquidity, and growth prospects. The study found an improvement in EPS, and decline in EBIT, Return on Assets indicating a negative impact of these variables on merger. The study also found the decline in Current Ratio, Quick Ratio, Debt/Equity, and Interest Coverage Ratio of selected companies post merger. The growth prospect of the selected companies also shows a negative impact on merger. The overall performance indicates that the merger has not benefited the selected companies due to ineffective management of the financial resources. The comparative analysis also showed a declining trend of most the selected companies post merger. Only torrent pharma showed better performance in profitability compared to the average. Sun pharma and Cipla have shown better performance of liquidity and Sun pharma and Torrent have shows better growth prospects.

Merger, Acquisition, Pharma, Profitability, Liquidity, Growth

"Pre and Post Merger Financial Performance of Select Indian Pharmaceutical Companies", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.7, Issue 12, page no.1246-1261, December-2020, Available :http://www.jetir.org/papers/JETIR2012366.pdf

"Pre and Post Merger Financial Performance of Select Indian Pharmaceutical Companies", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.7, Issue 12, page no. pp1246-1261, December-2020, Available at : http://www.jetir.org/papers/JETIR2012366.pdf